356 related articles for article (PubMed ID: 11552995)
1. Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells.
Lehmann C; Zeis M; Uharek L
Br J Haematol; 2001 Sep; 114(3):660-5. PubMed ID: 11552995
[TBL] [Abstract][Full Text] [Related]
2. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
[TBL] [Abstract][Full Text] [Related]
3. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
Lehmann C; Zeis M; Schmitz N; Uharek L
Blood; 2000 Jul; 96(2):594-600. PubMed ID: 10887123
[TBL] [Abstract][Full Text] [Related]
4. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
Mori S; Jewett A; Murakami-Mori K; Cavalcanti M; Bonavida B
Cancer Immunol Immunother; 1997 Jul; 44(5):282-90. PubMed ID: 9247563
[TBL] [Abstract][Full Text] [Related]
5. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
6. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity.
Gardiner CM; Reen DJ
Immunology; 1998 Apr; 93(4):511-7. PubMed ID: 9659223
[TBL] [Abstract][Full Text] [Related]
7. Effects of interleukins 2 and 12 on the levels of granzyme B and perforin and their mRNAs in tributyltin-exposed human natural killer cells.
Thomas LD; Shah H; Bankhurst AD; Whalen MM
Arch Toxicol; 2005 Dec; 79(12):711-20. PubMed ID: 16032371
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
9. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
10. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
[TBL] [Abstract][Full Text] [Related]
11. Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway.
Wei S; Gilvary DL; Corliss BC; Sebti S; Sun J; Straus DB; Leibson PJ; Trapani JA; Hamilton AD; Weber MJ; Djeu JY
J Immunol; 2000 Oct; 165(7):3811-9. PubMed ID: 11034387
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
13. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
Ebert EC
Clin Exp Immunol; 2004 Nov; 138(2):259-65. PubMed ID: 15498035
[TBL] [Abstract][Full Text] [Related]
15. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity.
Hazeldine J; Hampson P; Lord JM
Aging Cell; 2012 Oct; 11(5):751-9. PubMed ID: 22642232
[TBL] [Abstract][Full Text] [Related]
16. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
17. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
[TBL] [Abstract][Full Text] [Related]
18. Early pregnancy decidual lymphocytes beside perforin use Fas ligand (FasL) mediated cytotoxicity.
Crncic TB; Laskarin G; Frankovic KJ; Tokmadzic VS; Strbo N; Bedenicki I; Le Bouteiller P; Tabiasco J; Rukavina D
J Reprod Immunol; 2007 Apr; 73(2):108-117. PubMed ID: 16950518
[TBL] [Abstract][Full Text] [Related]
19. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice.
Argentati K; Bartozzi B; Bernardini G; Di Stasio G; Provinciali M
Eur Cytokine Netw; 2000 Mar; 11(1):59-66. PubMed ID: 10705300
[TBL] [Abstract][Full Text] [Related]
20. Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells.
Clément MV; Haddad P; Soulié A; Legros-Maida S; Guillet J; Cesar E; Sasportes M
Res Immunol; 1990; 141(6):477-89. PubMed ID: 2284495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
